The board of directors of the Certification Board for Sterile Processing & Distribution, Inc. (CBSPD) announces that the Flexible Endoscope Reprocessor and Management certifications examinations have received full accreditation from the National Commission for Certifying Agencies until Oct. 31, 2020.
This accreditation validates the processes implemented by the CBSPD in 1988 when the organization was formed and are followed to this day. The CBSPD board also commends the CBSPD staff and Seacrest Company who prepared the accreditations applications. Many individuals have provided the expertise to maintain the high quality, secure certifications programs. These individuals include the members of the CBSPD Item Review Committee and the CBSPD Continuing Education Committee, among others.
The CBSPD offers five certification programs: Certified Sterile Processing & Distribution Technician, Certified Surgical Instrument Specialist, Certified in Sterile Processing Management, Certified Ambulatory Surgery Sterile Processing Technician and Certified Flexible Endoscope Reprocessor.
Source: CBSPD
New UV-C Disinfection Technology for Ultrasound Probes Earns FDA Clearance
September 4th 2024Chronos, a chemical-free UV-C disinfection device for ultrasound probes, received FDA clearance. It offers health care professionals a fast, automated solution to reduce cross-contamination and improve infection prevention.
Addressing Sterile Processing Instrument Errors With Advanced Technology and Data Insights
September 3rd 2024Surgical instrument errors, often linked to visualization failures during sterile processing, pose significant risks to patient safety and OR efficiency. Advanced technologies, including AI, are essential for reducing these errors and improving overall outcomes in sterile processing departments.
Implementing FDA 21 CFR Part 820 & ISO 13485 on Quality System Regulation
August 30th 2024The FDA's 21 CFR Part 820 and ISO 13485 are crucial in regulating medical device quality systems. Harmonizing these standards by 2026 will streamline compliance, improve patient access to devices, and align US regulations with global practices.